Dosidal · Belgium
Cosopt Unit Dose 20 mg/ml - 5 mg/ml
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | Belgium |
|---|---|
| Record | be:presentation:cti:291663-01 (version 1) |
| Level | presentation |
| Pack code | not anchored |
| Identifiers | be-cti-extended: 291663-01 be-authorisation: BE291663 |
| Source authority | FAMHP |
| Read date | 2026-11-15T03:58:09Z |
| authorisation status | amp_status: AUTHORIZED ampp_status: AUTHORIZED commercialised_now: False lifecycle: current period_from: 2007-02-26 supply_problem_now: False state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| controlled status | state: unknown |
| identity | amp_code: SAM291663-00 atc: S01ED51 authorisation_number: BE291663 cti_extended: 291663-01 form: Eye drops, solution holder: Santen medicine_type: ALLOPATHIC name: Cosopt Unit Dose 20 mg/ml - 5 mg/ml pack: 30 x 0.2 ml parallel_circuit: 0 parallel_import: False substances: strength: 6.8300 mg/mL substance: Timolol Maleate; strength: 22.2300 mg/mL substance: Dorzolamide Hydrochloride state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| pack product code | fmd_in_scope: True note: no FMD product code and no CNK in SAM state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| prescription class | as_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006 class: prescription delivery_modus: M1 state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d536jCtlkE5P1sm6YFgxxqSrFSrn-1qdmyhiDN236tXX1zV3LBds7KhwzPhpmVZgcX3kV_3FsjiYOtd0FYE3QS5UwVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |
JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:291663-01 · Same medicine in other markets · Dosidal